JP2023521161A - 臓器傷害の予防及び処置 - Google Patents
臓器傷害の予防及び処置 Download PDFInfo
- Publication number
- JP2023521161A JP2023521161A JP2022561995A JP2022561995A JP2023521161A JP 2023521161 A JP2023521161 A JP 2023521161A JP 2022561995 A JP2022561995 A JP 2022561995A JP 2022561995 A JP2022561995 A JP 2022561995A JP 2023521161 A JP2023521161 A JP 2023521161A
- Authority
- JP
- Japan
- Prior art keywords
- injury
- infection
- respiratory
- compound
- use according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
- A61K38/13—Cyclosporins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Materials For Medical Uses (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2020/084820 | 2020-04-15 | ||
| CN2020084820 | 2020-04-15 | ||
| CNPCT/CN2021/081574 | 2021-03-18 | ||
| CN2021081574 | 2021-03-18 | ||
| PCT/CN2021/087501 WO2021209003A1 (en) | 2020-04-15 | 2021-04-15 | Prevention and treatment of organ injuries |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023521161A true JP2023521161A (ja) | 2023-05-23 |
| JP2023521161A5 JP2023521161A5 (cg-RX-API-DMAC7.html) | 2024-04-24 |
Family
ID=78085285
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022561995A Pending JP2023521161A (ja) | 2020-04-15 | 2021-04-15 | 臓器傷害の予防及び処置 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US12465629B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4135743A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2023521161A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20230002589A (cg-RX-API-DMAC7.html) |
| CN (2) | CN114245744A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021256222A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3174545A1 (cg-RX-API-DMAC7.html) |
| TW (1) | TWI889805B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021209003A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3172535A1 (en) | 2020-03-26 | 2021-09-30 | Ching-Pong Mak | Cyclophilin inhibitors and uses thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08298986A (ja) * | 1995-04-28 | 1996-11-19 | Asahi Chem Ind Co Ltd | ホスホリパーゼa2酵素 |
| WO2019016572A1 (en) * | 2017-07-21 | 2019-01-24 | Cypralis Ltd | CICLOSPORINE ANALOGUES AND USES THEREOF |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0194972B1 (en) | 1985-03-11 | 1992-07-29 | Sandoz Ag | Novel cyclosporins |
| FI111730B (fi) | 1990-11-02 | 2003-09-15 | Novartis Ag | Menetelmä ei-immunosuppressiivisen syklosporiinin valmistamiseksi |
| KR970064620A (ko) | 1996-03-05 | 1997-10-13 | 임성기 | 사이클로스포린-함유 외용약제 조성물 |
| ATE254630T1 (de) | 1998-06-12 | 2003-12-15 | Chem Ag C | Cyclosporine |
| CN101068829B (zh) | 2004-10-01 | 2012-05-30 | 西尼克斯公司 | 用于治疗和预防丙型肝炎病毒感染的3-醚和3-硫醚取代的环孢菌素衍生物 |
| PT1802650E (pt) * | 2004-10-01 | 2011-12-30 | Scynexis Inc | Derivados da ciclosporina 3-éter e 3-tioéter substituída para o tratamento e prevenção da infecção de hepatite c |
| WO2007041632A2 (en) * | 2005-09-30 | 2007-04-12 | Scynexis, Inc. | Methods and pharmaceutical compositions for the treatment and prevention of hepatitis c infection |
| BRPI0708424A2 (pt) | 2006-03-02 | 2011-05-31 | Alexion Pharma Inc | prolongamento da sobreviência de uma aloenxerto por inibição da atividade do complemento |
| CA2652662C (en) * | 2006-05-19 | 2015-11-03 | Scynexis, Inc. | Methods for the treatment and prevention of ocular disorders |
| WO2008143996A1 (en) | 2007-05-18 | 2008-11-27 | Scynexis, Inc. | New chemical processes |
| US8536114B2 (en) | 2008-12-31 | 2013-09-17 | Scynexis, Inc. | Macrocycles |
| US9217015B2 (en) | 2010-07-16 | 2015-12-22 | S&T Global Inc. | Cyclosporin derivatives for the treatment and prevention of a viral infection |
| MX350746B (es) * | 2010-12-03 | 2017-09-14 | Hebei Kunxiangjishi Pharmaceutical Tech Co Ltd | Derivados de ciclosporina novedosos para el tratamiento y la prevención de una infección viral. |
| GB201217560D0 (en) | 2012-10-02 | 2012-11-14 | Mitopharm Ltd | Novel cyclic depsipeptide compounds and their uses |
| TW201639873A (zh) | 2015-01-08 | 2016-11-16 | 歐樂根公司 | Mebmt側鏈已環化之環孢菌素衍生物 |
| CN105983095B (zh) * | 2015-02-15 | 2019-09-13 | 艾棣维欣(苏州)生物制药有限公司 | 一种呼吸道合胞体病毒疫苗及其制备方法与应用 |
| CN106902346A (zh) | 2015-12-23 | 2017-06-30 | 中美华世通生物医药科技(武汉)有限公司 | 药物组合物及其制药用途 |
| CN106902347A (zh) * | 2015-12-23 | 2017-06-30 | 中美华世通生物医药科技(武汉)有限公司 | 亲环孢素抑制剂的用途 |
| CN111449050A (zh) | 2019-01-20 | 2020-07-28 | 睿诺医疗科技(上海)有限公司 | 环孢菌素类似物及其用途 |
| CN116870135A (zh) * | 2019-10-12 | 2023-10-13 | 睿诺医疗科技(上海)有限公司 | 肾毒素诱发的肾损伤的治疗和预防 |
| CA3172535A1 (en) | 2020-03-26 | 2021-09-30 | Ching-Pong Mak | Cyclophilin inhibitors and uses thereof |
| WO2021190603A1 (en) | 2020-03-26 | 2021-09-30 | Farsight Medical Technology (Shanghai) Co., Ltd. | Cyclophilin inhibitors and uses thereof |
-
2021
- 2021-04-15 AU AU2021256222A patent/AU2021256222A1/en not_active Abandoned
- 2021-04-15 CN CN202180001578.7A patent/CN114245744A/zh active Pending
- 2021-04-15 US US17/995,992 patent/US12465629B2/en active Active
- 2021-04-15 KR KR1020227038978A patent/KR20230002589A/ko active Pending
- 2021-04-15 WO PCT/CN2021/087501 patent/WO2021209003A1/en not_active Ceased
- 2021-04-15 TW TW110113545A patent/TWI889805B/zh active
- 2021-04-15 CN CN202110951301.2A patent/CN113694177B/zh active Active
- 2021-04-15 EP EP21788345.3A patent/EP4135743A4/en active Pending
- 2021-04-15 CA CA3174545A patent/CA3174545A1/en active Pending
- 2021-04-15 JP JP2022561995A patent/JP2023521161A/ja active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH08298986A (ja) * | 1995-04-28 | 1996-11-19 | Asahi Chem Ind Co Ltd | ホスホリパーゼa2酵素 |
| WO2019016572A1 (en) * | 2017-07-21 | 2019-01-24 | Cypralis Ltd | CICLOSPORINE ANALOGUES AND USES THEREOF |
Non-Patent Citations (2)
| Title |
|---|
| "タゾバクタム/ピペラシリン、ペニシリン系", 抗菌薬インターネットブック, JPN6025033035, 2012, ISSN: 0005667951 * |
| BIOCHIMICA ET BIOPHYSICA ACTA, JPN6025006681, 2015, pages 2563 - 2573, ISSN: 0005532710 * |
Also Published As
| Publication number | Publication date |
|---|---|
| TW202143995A (zh) | 2021-12-01 |
| CA3174545A1 (en) | 2021-10-21 |
| CN113694177B (zh) | 2022-06-17 |
| AU2021256222A1 (en) | 2022-10-06 |
| EP4135743A4 (en) | 2024-05-22 |
| CN113694177A (zh) | 2021-11-26 |
| US20230181680A1 (en) | 2023-06-15 |
| WO2021209003A1 (en) | 2021-10-21 |
| KR20230002589A (ko) | 2023-01-05 |
| EP4135743A1 (en) | 2023-02-22 |
| TWI889805B (zh) | 2025-07-11 |
| US12465629B2 (en) | 2025-11-11 |
| CN114245744A (zh) | 2022-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090197941A1 (en) | Pharmaceutical Compositons for the Treatment of Chronic Obstructive Pulmonary Disease | |
| TWI889805B (zh) | 器官損傷的預防和治療 | |
| CN118806741B (zh) | 二氢青蒿酸在制备预防或治疗急性肺损伤的药物中的应用 | |
| EP2608783A1 (en) | Use of glycyrrhetinic acid, glycyrrhizic acid and related compounds for prevention and/or treatment of pulmonary fibrosis | |
| EP4346789B1 (en) | Capsaicin derivatives in the treatment of idiopathic pulmonary fibrosis | |
| US11534398B2 (en) | Inhaled preparation of isoglycyrrhizic acid or salt thereof, and use in preparing drugs for treating respiratory system diseases | |
| US8420697B2 (en) | Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom | |
| CN112121045A (zh) | 肺炎患儿纤支镜手术用麻醉抗炎药物组合物和麻醉抗炎的方法 | |
| RU2451507C2 (ru) | Лекарственное средство для лечения хронического обструктивного заболевания легких | |
| TW202504602A (zh) | 用於治療臟器纖維化相關疾病的藥物組合物和方法 | |
| JP2016027032A (ja) | 慢性閉塞性肺疾患治療剤 | |
| EA052469B1 (ru) | Лечение некистозных фиброзных (немуковисцидозных) бронхоэктазов | |
| RU2600822C1 (ru) | Способ лечения хронического обструктивного бронхита | |
| US20220054509A1 (en) | Methods of treatment for disease from coronavirus exposure | |
| Dal Negro et al. | Use of aerosols in bronchiectasis patients | |
| Oswald | Chronic coughing in dogs and cats-my favorite drugs. | |
| HK1166934A (en) | Treatment of acute exacerbation of asthma and reduction of likelihood of hospitalization of patients suffering therefrom | |
| KR20130038583A (ko) | 소포체 스트레스 억제제를 유효성분으로 함유하는 급성 폐 손상의 예방 또는 치료용 약학 조성물 | |
| JP2023158351A (ja) | コロナウイルス感染症の後遺症を処置または予防するための医薬組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240412 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240412 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20250220 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20250226 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20250519 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20250820 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251219 |